Baker Brothers Life Sciences LP, Director, 10% Owner at Kodiak Sciences Inc. (KOD), bought 63,276 shares at $94.59 ($6.0M) on 2021-09-16, disclosed to the SEC on 2021-09-17.
Open-market purchase of $6.0M KOD by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.38 | 30,285 | $2.9M | 47.9% |
| 2 | $94.38 | 30,285 | $2.9M | 47.9% |
| 3 | $94.48 | 400 | $38K | 0.6% |
| 4 | $94.59 | 1,153 | $109K | 1.8% |
| 5 | $94.59 | 1,153 | $109K | 1.8% |
| Total | $94.39 avg | 63,276 |
| $6.0M |
| 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |